393 related articles for article (PubMed ID: 11557915)
1. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men.
Dishy V; Sofowora G; Harris PA; Kandcer M; Zhan F; Wood AJ; Stein CM
Clin Pharmacol Ther; 2001 Sep; 70(3):270-9. PubMed ID: 11557915
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic sildenafil treatment on penile endothelial function: a randomized, double-blind, placebo controlled study.
Vardi Y; Appel B; Ofer Y; Greunwald I; Dayan L; Jacob G
J Urol; 2009 Dec; 182(6):2850-5. PubMed ID: 19837434
[TBL] [Abstract][Full Text] [Related]
3. Type 5 phosphodiesterase inhibition by sildenafil abrogates acute smoking-induced endothelial dysfunction.
Vlachopoulos C; Tsekoura D; Alexopoulos N; Panagiotakos D; Aznaouridis K; Stefanadis C
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1040-4. PubMed ID: 15533731
[TBL] [Abstract][Full Text] [Related]
4. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
Attinà TM; Malatino LS; Maxwell SR; Padfield PL; Webb DJ
J Hypertens; 2008 Mar; 26(3):501-7. PubMed ID: 18300861
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil does not improve nitric oxide-mediated endothelium-dependent vascular responses in smokers.
Dishy V; Harris PA; Pierce R; Prasad HC; Sofowora G; Bonar HL; Wood AJ; Stein CM
Br J Clin Pharmacol; 2004 Feb; 57(2):209-12. PubMed ID: 14748820
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of sildenafil on flow mediated dilatation and cardiovascular autonomic nerve function in type 2 diabetic patients.
Stirban A; Laude D; Elghozi JL; Sander D; Agelink MW; Hilz MJ; Ziegler D
Diabetes Metab Res Rev; 2009 Feb; 25(2):136-43. PubMed ID: 19116943
[TBL] [Abstract][Full Text] [Related]
8. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.
Schäfer A; Fraccarollo D; Pförtsch S; Flierl U; Vogt C; Pfrang J; Kobsar A; Renné T; Eigenthaler M; Ertl G; Bauersachs J
Br J Pharmacol; 2008 Mar; 153(5):886-93. PubMed ID: 17891166
[TBL] [Abstract][Full Text] [Related]
9. PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers.
Kimura M; Higashi Y; Hara K; Noma K; Sasaki S; Nakagawa K; Goto C; Oshima T; Yoshizumi M; Chayama K
Hypertension; 2003 May; 41(5):1106-10. PubMed ID: 12695418
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.
Aversa A; Vitale C; Volterrani M; Fabbri A; Spera G; Fini M; Rosano GM
Diabet Med; 2008 Jan; 25(1):37-44. PubMed ID: 18199130
[TBL] [Abstract][Full Text] [Related]
11. No adverse hemodynamic interaction between sildenafil and red wine.
Leslie SJ; Atkins G; Oliver JJ; Webb DJ
Clin Pharmacol Ther; 2004 Oct; 76(4):365-70. PubMed ID: 15470336
[TBL] [Abstract][Full Text] [Related]
12. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.
Mahmud A; Hennessy M; Feely J
J Hum Hypertens; 2001 Oct; 15(10):707-13. PubMed ID: 11607801
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.
Yuan Z; Hein TW; Rosa RH; Kuo L
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):720-5. PubMed ID: 18235020
[TBL] [Abstract][Full Text] [Related]
14. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia.
Halcox JP; Nour KR; Zalos G; Mincemoyer RA; Waclawiw M; Rivera CE; Willie G; Ellahham S; Quyyumi AA
J Am Coll Cardiol; 2002 Oct; 40(7):1232-40. PubMed ID: 12383570
[TBL] [Abstract][Full Text] [Related]
15. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
16. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
[TBL] [Abstract][Full Text] [Related]
17. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
18. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
Meyer MF; Lieps D; Schatz H; Pfohl M
Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131
[TBL] [Abstract][Full Text] [Related]
19. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress.
Goto C; Higashi Y; Kimura M; Noma K; Hara K; Nakagawa K; Kawamura M; Chayama K; Yoshizumi M; Nara I
Circulation; 2003 Aug; 108(5):530-5. PubMed ID: 12874192
[TBL] [Abstract][Full Text] [Related]
20. Comparative relaxing effects of sildenafil, vardenafil, and tadalafil in human corpus cavernosum: contribution of endogenous nitric oxide release.
Toque HA; Priviero FB; Teixeira CE; Claudino MA; Baracat JS; Fregonesi A; De Nucci G; Antunes E
Urology; 2009 Jul; 74(1):216-21. PubMed ID: 19371941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
